This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (165)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Thrombolysis  • Venous Thromboembolism  • Cardiovascular System  • Alert me on articles by topic  Social Bookmarking   What's this?

A Comparison of Patient Self-Injection With Homecare Injection

Philip S. Wells, MD, FRCPC, MSc; Michael J. Kovacs, MD, FRCPC; Janis Bormanis, MD, FRCPC; Melissa A. Forgie, MD, FRCPC; Donna Goudie, RN; Bev Morrow, RN; Judy Kovacs, RN

Arch Intern Med. 1998;158:1809-1812.

Background  The outpatient treatment of patients with deep vein thrombosis and pulmonary embolism using low-molecular-weight heparin has the potential to reduce health care costs, but it is unclear if most patients with deep vein thrombosis and pulmonary embolism can be treated as outpatients. In the published studies, more than 50% of patients were excluded from outpatient treatment for reasons such as comorbid conditions, short life expectancy, concomitant pulmonary embolism, and previous deep vein thrombosis, and many patients were not treated entirely at home. We sought to determine if expanding patient eligibility for the outpatient treatment of deep vein thrombosis and pulmonary embolism affects the safety and effectiveness of the treatment, and to determine if patient self-injection compared with injections administered by a homecare nurse affected these outcomes.

Patients and Methods  We treated as outpatients all patients with deep vein thrombosis and pulmonary embolism, except for those with massive pulmonary embolism, high risk for major bleeding or an active bleed, phlegmasia, and patients hospitalized for reasons that prevented discharge. We compared 2 models of outpatient care to determine feasibility, safety, and efficacy. Both models involved nurse managers who provided daily patient contact and ongoing treatment; however, in one model the patients were taught to inject themselves and in the other model homecare nurses administered the injections. We expanded the population of patients eligible for outpatient treatment by including many patients not treated at home in previous studies. Most patients in our study were treated with dalteparin sodium, 200 U/kg every 24 hours, for a minimum of 5 days. Therapy with warfarin sodium was started on the day of diagnosis or the following day. Patients were followed up for 3 months to determine rates of recurrent venous thromboembolism, bleeding, and death.

Results  In this study, 194 (83%) of 233 consecutive patients were deemed eligible and treated as outpatients. Of the 39 patients who did not receive home therapy, 20 had concomitant medical problems responsible for their admission or were already inpatients, 6 had massive pulmonary embolism, 6 refused to pay for the dalteparin therapy, 4 had active bleeding, and 3 had phlegmasia cerulea dolens, which required treatment with intravenous narcotics for pain control. More than 184 (95%) of the 194 patients were treated entirely at home. There was no significant difference (P>.99) in the rate of recurrent venous thromboembolic events between the patients who were injected by homecare nurses (3/95 [3.2]) and those who injected themselves (4/99 [4.0]). Combining the 2 models, the overall recurrent event rate was 3.6% (95% confidence interval, 1.5%-7.4%). Similarly, there were no significant differences in rates of major hemorrhage (2/95 vs 2/99; P>.99), minor hemorrhage (8/95 vs 2/99; P=.06), and death (6/95 vs 8/99; P =.63). The overall rate of major hemorrhage was 2.0% (95% confidence interval, 0.6%-5.2%).

Conclusions  We demonstrate that more than 80% of patients at our tertiary care hospital could be treated at home using 1 of the 2 models of care we describe. Our results demonstrate that patients can safely and effectively perform home self-injection under the supervision of a hospital-based nurse. Injections at home by a homecare nurse are similarly effective. Our overall rates of recurrent venous thromboembolism, bleeding, and death are at least as favorable as those previously reported despite using 1 dose per day of dalteparin for most patients.

From the Department of Medicine, University of Ottawa, Ottawa, Ontario (Drs Wells, Bormanis, and Forgie, and Ms Goudie), and the University of Western Ontario, London (Dr Kovacs and Mss Morrow, and Kovacs).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
Squizzato et al.
Eur Respir J 2009;33:1148-1155.
ABSTRACT | FULL TEXT  

Treatment of Venous Thromboembolism in Patients with Cancer
Lee
Am Soc Clin Oncol Ed Book 2009;2009:331-336.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Kearon et al.
Chest 2008;133:454S-545S.
ABSTRACT | FULL TEXT  

Initial management of deep venous thrombosis in the outpatient setting
Groce
Am J Health Syst Pharm 2008;65:866-874.
FULL TEXT  

Length of Hospital Stay and Postdischarge Mortality in Patients With Pulmonary Embolism: A Statewide Perspective
Aujesky et al.
Arch Intern Med 2008;168:706-712.
ABSTRACT | FULL TEXT  

Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index?
Otero et al.
Eur Respir J 2007;30:1111-1116.
ABSTRACT | FULL TEXT  

Home at last? Early discharge for acute pulmonary embolism
Tapson and Huisman
Eur Respir J 2007;30:613-615.
FULL TEXT  

Early discharge of patients with pulmonary embolism: a two-phase observational study
Davies et al.
Eur Respir J 2007;30:708-714.
ABSTRACT | FULL TEXT  

Prognostic Models for Selecting Patients With Acute Pulmonary Embolism for Initial Outpatient Therapy
Jimenez et al.
Chest 2007;132:24-30.
ABSTRACT | FULL TEXT  

A simple prediction rule identified patients with pulmonary embolism at low risk of short term death
O'Flaherty and Gandara
Evid. Based Med. 2006;11:121-121.
FULL TEXT  

Validation of a model to predict adverse outcomes in patients with pulmonary embolism
Aujesky et al.
Eur Heart J 2006;27:476-481.
ABSTRACT | FULL TEXT  

A Prediction Rule to Identify Low-Risk Patients With Pulmonary Embolism
Aujesky et al.
Arch Intern Med 2006;166:169-175.
ABSTRACT | FULL TEXT  

How I treat venous thromboembolism in patients with cancer
Prandoni
Blood 2005;106:4027-4033.
ABSTRACT | FULL TEXT  

Derivation and Validation of a Prognostic Model for Pulmonary Embolism
Aujesky et al.
Am. J. Respir. Crit. Care Med. 2005;172:1041-1046.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Low-Molecular-Weight Heparin for Treatment of Pulmonary Embolism
Aujesky et al.
Chest 2005;128:1601-1610.
ABSTRACT | FULL TEXT  

Outpatient treatment of venous thromboembolic disease based in an emergency department
Zed et al.
Am J Health Syst Pharm 2005;62:616-619.
ABSTRACT | FULL TEXT  

Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism
McGuire and Dobesh
Journal of Pharmacy Practice 2004;17:289-307.
ABSTRACT  

Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin
Kovacs et al.
Circulation 2004;110:1658-1663.
ABSTRACT | FULL TEXT  

Initial Treatment of Venous Thromboembolism
McRae and Ginsberg
Circulation 2004;110:I-3-I-9.
ABSTRACT | FULL TEXT  

Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial
Stellbrink et al.
Circulation 2004;109:997-1003.
ABSTRACT | FULL TEXT  

Effect of Intravenous Heparin Administration on Duration of Hospitalization
Dunn et al.
Mayo Clin Proc. 2004;79:159-163.
ABSTRACT  

Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism: A Meta-Analysis
Linkins et al.
ANN INTERN MED 2003;139:893-900.
ABSTRACT | FULL TEXT  

Outpatient treatment of pulmonary embolism
Hogg and Dawson
Emerg. Med. J. 2003;20:370-371.
ABSTRACT | FULL TEXT  

Hospital Guidelines for Use of Low-Molecular-Weight Heparins
Nutescu et al.
The Annals of Pharmacotherapy 2003;37:1072-1081.
ABSTRACT | FULL TEXT  

The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis
van Dongen et al.
Arch Intern Med 2003;163:1285-1293.
ABSTRACT | FULL TEXT  

British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
Thorax 2003;58:470-483.
FULL TEXT  

Comparison of 10-mg and 5-mg Warfarin Initiation Nomograms Together with Low-Molecular-Weight Heparin for Outpatient Treatment of Acute Venous Thromboembolism: A Randomized, Double-Blind, Controlled Trial
Kovacs et al.
ANN INTERN MED 2003;138:714-719.
ABSTRACT | FULL TEXT  

Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT | FULL TEXT  

Extended Venous Thromboembolism Prophylaxis After Total Hip Replacement: A Comparison of Low-Molecular-Weight Heparin With Oral Anticoagulant
Samama et al.
Arch Intern Med 2002;162:2191-2196.
ABSTRACT | FULL TEXT  

Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip Arthroplasty: A Systematic Review
Hull et al.
ANN INTERN MED 2001;135:858-869.
ABSTRACT | FULL TEXT  

Eligibility criteria for home treatment of DVT vary
Vinson
BMJ 2001;323:866-866.
FULL TEXT  

Routine home treatment of deep vein thrombosis
Eikelboom and Baker
BMJ 2001;322:1192-1193.
FULL TEXT  

Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
Douketis et al.
Arch Intern Med 2000;160:3431-3436.
ABSTRACT | FULL TEXT  

Outpatient treatment for patients with uncomplicated above knee deep vein thrombosis
Lane and Harrison
Emerg. Med. J. 2000;17:403-404.
FULL TEXT  

Effectiveness and Economic Impact Associated With a Program for Outpatient Management of Acute Deep Vein Thrombosis in a Group Model Health Maintenance Organization
Tillman et al.
Arch Intern Med 2000;160:2926-2932.
ABSTRACT | FULL TEXT  

Vena caval filters: a comprehensive review
Streiff
Blood 2000;95:3669-3677.
ABSTRACT | FULL TEXT  

Eligibility for Outpatient Treatment With Low-Molecular-Weight Heparin in Venous Thromboembolism
Tanvetyanon and Cohn
Arch Intern Med 2000;160:869-870.
FULL TEXT  

The Safety, Efficacy, and Cost Efficiency of Outpatient Treatment of Acute Deep Venous Thrombosis with Low Molecular Weight Heparin
Wakefield
PERSPECT VASC SURG ENDOVASC THER 2000;13:19-25.
ABSTRACT  

Cancer, Coagulation, and Anticoagulation
Letai and Kuter
The Oncologist 1999;4:443-449.
ABSTRACT | FULL TEXT  

Outpatient Treatment of Deep Venous Thrombosis
Carman et al.
Chest 1999;116:1492-1493.
FULL TEXT  

Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis
O'Brien et al.
Arch Intern Med 1999;159:2298-2304.
ABSTRACT | FULL TEXT  

Subcutaneous Heparin for Deep Venous Thrombosis
Alatri et al.
ANN INTERN MED 1999;130:1027-1027.
FULL TEXT  

Outpatient Treatment of DVT: Self- vs. Nurse-Injection of LMWH
JWatch Emergency Med. 1998;1998:22-22.
FULL TEXT